Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Cue Biopharma, Inc. | d859387dex321.htm |
| EX-31.2 - EX-31.2 - Cue Biopharma, Inc. | d859387dex312.htm |
| EX-31.1 - EX-31.1 - Cue Biopharma, Inc. | d859387dex311.htm |
| 10-K/A - 10-K/A - Cue Biopharma, Inc. | d859387d10ka.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (No. 333-229140) on Form S-3 and Registration Statements (Nos. 333-224018 and 333-230282) on Form S-8 of Cue Biopharma, Inc. of our report dated March 11, 2020, relating to the consolidated financial statements of Cue Biopharma, Inc. and Subsidiary, appearing in this Annual Report on Form 10-K of Cue Biopharma, Inc. for the year ended December 31, 2019.
/s/ RSM US LLP
Boston, Massachusetts
March 12, 2020